You are here: Industry Insights > Market News > Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Benfotiamine

Nicarbazin

9-Phenyl-9H,9'H-[3,3']bicarbazolyl

1-Bromo-3,5-diphenylbenzene

9-Anthraceneboronic acid

1-bromo-7-chlorodibenzo[b,d]furan

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

expresspharmaJune 08, 2020

Tag: Remdesivir , Maharashtra , coronavirus , COVID-19

Favorites

The Maharashtra government will procure 10,000 vials of the drug Remdesivir for treating coronavirus patients, informed Rajesh Tope, Public Health Minister.

The expensive medicine is being made available for the poor and needy patients in the state, he said.

“GoM to procure 10k vials of remdesivir. Based on evidence from laboratory, animal and clinical studies, it has generated promising results in MERS-CoV and SARS which are also caused by coronavirus,” Tope tweeted.

“WHO suggests it may have some positive effects on COVID-19 treatment. This expensive medicine is being made available for poor & needy patients,” he added.

Previous:Ministry of Health publishes draft New Drugs and Clinical Trials (Amendment) Rules

Next:Shanghai Junshi Biosciences starts human tests for coronavirus antibody drug

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may like
More>>

Maharashtra to procure 10,000 vials of remdesivir: Rajesh Tope

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>